Short talks Pharmacology 14
Drug biodistribution and safety

Programme

• 08:30 – 08:45 10 Min. 5 Min.

  • Short talk
  • 63

  A post-transcriptional mechanism likely explains the weaker CYP3A4 induction effect of rifabutin compared to rifampicin.

  • Dirk Theile (Heidelberg / DE)

   Drug transport/delivery and metabolism
• 08:45 – 09:00 10 Min. 5 Min.

  • Short talk
  • 64

  Polychlorinated biphenyls (PCBs) interact with drug metabolism in humans

  • Jens Rengelshausen (Aachen / DE)

   Pharmacoepidemiology and drug safety
• 09:00 – 09:15 10 Min. 5 Min.

  • Short talk
  • 65

  Alternative phamaco- epidemiological confounding factors versus acetylsalicylic acid (ASS) as one suspect associated factor with Reye's syndrome in children.

  • Hubert Heuer (Schwabenheim / DE)

   Pharmacoepidemiology and drug safety
• 09:15 – 09:30 10 Min. 5 Min.

  • Short talk
  • 66

  Clinical implementation and adaptation of pharmacogenomics testing in a German academic teaching hospital and outpatient setting

  • Filippa Schreeck (Stuttgart / DE)
  • Roman Tremmel (Stuttgart / DE)

   Pharmacogenomics and personalized medicine
• 09:30 – 09:45 10 Min. 5 Min.

  • Short talk
  • 67

  Influence of Obesity on Cefuroxime Pharmacokinetics

  • Hannes Warschewske (Greifswald / DE)

   Pharmacokinetics and PK/PD modelling
• 09:45 – 10:00 10 Min. 5 Min.

  • Short talk
  • 68

  The applicability of "nicotine flux" in tobacco products regulation

  • Carrie Wade (Lausanne / CH)

   Pharmacokinetics and PK/PD modelling